Advertisement

AgeX Therapeutics, Inc. AGE

Set alert

Price alert · AGE

All alert types
11.10 +11.10 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
27.76M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
0.00
Beta
1.19
Short ratio
3.88
Inst. own
0.00%
Dividend
0.00
Ex-div date
50-d avg
13.98
200-d avg
19.89
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for AGE has not been loaded yet. Try again in a moment.

Revenue & Expenses

Net Loss → Expenses: $6.45MExpenses → Selling, General & Admin: $2.54MExpenses → Research & Development: $3.15MExpenses → Interest Expense: $9.00KExpenses → Other Expenses: $744.00KNet Loss$6.45MExpenses$6.45MSelling, General & Admin$2.54MResearch & Development$3.15MInterest Expense$9.00KOther Expenses$744.00KRevenue$130.00K

Period ending Sep 30, 2023 · select a line to chart its history

Income statement

AGE quarterly income statement
67.00K
67.00K
33.00K
34.00K
2.39M
218.00K
2.17M
-2.35M
3.04M
-5.40M
-5.40M
-5.40M
-5.39M
12.00K
-0.14
-0.14
-0.14
-2.37M
-2.37M
37.95M
37.95M

Balance sheet

AGE quarterly balance sheet
447.00K
447.00K
10.38M
10.38M
71.00K
1.14M
12.21M
1.53M
2.22M
3.20M
693.00K
3.90M
-127.56M
-27.54M
-27.54M
11.07M
2.22M
640.00K
693.00K
1.67M

Cash flow

AGE quarterly cash flow
33.00K
2.00M
136.00K
2.00M
-1.86M
40.00K
Advertisement